ABSTRACT
Introduction
Acute bleeding is frequently associated with the need for transfusion of blood derivatives, especially red blood cells (RBCs). The administration of transfusion products containing cellular elements poses many risks and potential adverse effects. Due to the gradual decomposition of RBCs and as a result of the accumulation of products of cellular metabolism, i.e. anaerobic glycolysis, the biochemical composition of RBC concentrates changes. In particular, there is an increase in K + and lactate levels and a simultaneous decrease in pH, glucose and Na + levels. The storage time has no impact on Ca ++ levels in the RBC concentrate. The changes are proportional to the storage time. (1) Large-volume RBC transfusion may contribute to changes in the patients' plasma biochemical parameters (hyperkalemia) and may therefore be related not only to the volume of RBC products but also to storage duration. (2) Other changes include a reduction in red blood cell deformability, altered red blood cell adhesiveness and aggregability, and a reduction in 2,3-diphosphoglycerate and ATP. Bioactive compounds with proinflammatory effects also accumulate in the storage medium. These changes reduce posttransfusion viability of red blood cells. The clinical effects beyond posttransfusion viability are uncertain, but a growing body of evidence suggests that the storage lesion may reduce tissue oxygen availability, have proinflammatory and immunomodulatory effects, and influence morbidity and mortality. (3) 
Objectives
The study aimed at in vivo assessment of the impact of administered RBC concentrates on the levels of selected biochemical parameters (K + , lactate, pH, Na + , Ca ++ , glucose), depending on the volume and age of administered products. At the same time, biochemical changes occurring during the storage of these products were studied in vitro.
Materials and Methods
Given the methods of data collection, ethics committee approval for the study protocol was not needed. In a prospectively selected group of 46 patients needing RBC replacement and transfused with RBCs with various storage times, arterial blood samples were analyzed. The plasma levels of K + , lactate, pH, Na + , Ca ++ and glucose were measured before and after the administration of RBC products. The samples were obtained by collecting 0.5 mL of blood from the patients' arterial catheters using the Marquest Quik Arterial Blood Gas (ABG) sampler. The samples were analyzed on a Nova Biomedical Stat Profile CCX combined acid-base analyzer. Excluded were patients with renal failure (furosemide diuresis, urea > 20 mmol/L, creatinine > 300 mol/L, dialysis), manifest hepatic insufficiency (liver transaminases elevated to more than double the normal value, bilirubin > 25 mol/L) and those receiving noradrenaline at a dose > 0.1 g/kg/min to support their circulation. Also excluded were patients who were administered sodium bicarbonate during the study period or potassium chloride to treat their initial hypokalemia. At the same time, samples of RBCs administered to patients were prospectively studied. From a total of 354 RBC units (bags) administered to the patients, 80 units were sampled according to the length of storage in the blood bank to equally cover the entire recommended shelf time. The obtained data were plotted to show the dependence of the studied biochemical parameters (K + , lactate, pH, Na + , Ca ++ and glucose) in stored RBC products on their age. All the analyzed samples of RBC units met the following criteria: volume of 280±50 mL, Hb > 43 g/U, HCT 50-70%, white blood cells (WBC) < 1.2×10 9 /L, platelet count < 20×10 9 /L, plasma proteins < 2 g/L. Although the expiration time of RBC products was up to 42 days, they were recommended to be used no later than 35 days from collection. (4) The study was carried out in the inpatient ward of the Department of Anesthesiology, Resuscitation and Intensive Medicine, University Hospital Olomouc. The RBC concentrates were stored in the blood bank under normal conditions at 2-6 °C and were delivered to the patient's bed in an insulated box. Within 2 minutes from the removal and careful mixing of the content of the transfusion bag, a 0.5 mL sample of the RBC concentrate was taken using the Marquest Quik ABG sampler and analyzed on a Nova Biomedical Stat Profile CCX combined acid-base analyzer. The obtained samples were used to determine the dependence of changes in the studied parameters on the age of products. To preserve 1 RBC concentrate unit of the studied samples, 20 mL of SAGM (Sodium chloride-Adenine-GlucoseMannitol) solution and 100 mL of CPD (Citrate-Phosphate-Dextrose) solution were used (for the composition of both solutions see 
Results
The in vitro group comprised 80 RBC unit samples stored for 1-35 days. The analyzed samples were equally distributed throughout the interval so that on each day of storage in the blood bank, two samples were examined. 1. There was a steady increase in K + levels in the RBC concentrate depending on the storage time (table 2, figure 1 ). 2. There was a gradual decrease in the pH of the RBC concentrate depending on the storage time (table 2, figure 2 ). 3. There was a steady increase in lactate levels in the RBC concentrate depending on the storage time (table 2, figure 3 ). 4 . There was a decrease in Na + levels depending on the storage time (table 2, figure 4 (25) In the course of the study, a significant drop in potassium levels was noted in one of the cases. It occurred after the initiation of perioperative blood recuperation using the Cell Saver system. The salvaged blood (returning to the patient) was hypokalemic (2.7 mmol/L of K + ). In the system, suctioned blood is washed with heparinized saline containing no potassium. Excess fluid with ions and tissue detritus is removed by centrifugation. When being returned to the patient, blood is not commonly biochemically monitored and decreased potassium levels may not be noticed. In stored RBC concentrate, there is an increase in the levels of lactate, a product of anaerobic blood cell metabolism. The source of energy, glucose, is metabolized by glycolysis to lactate using two ATP molecules. When monitoring lactatemia in our study, a statistically significant difference between genders was observed, with lactate levels rising in males but falling in females. (26) The rate of administration of RBC concentrate is dependent on patient tolerance. The highest recommended rate is 100 mL/ min while the slowest administration of 1 RBC unit may take as much as 4 hours (the risk of bacterial contamination). If slower application is needed (in patients with cardiac failure), the blood bank should be asked for providing smaller bags. (27) The reason for decreased in vitro Na + concentration in RBCs is that the process of K + /Na + exchange between the intracellular and extracellular spaces is inhibited during storage of RBCs. However, decreased sodium levels in RBCs have no effect on in vivo sodium concentration after transfusion. This is likely because the decrease in sodium levels in RBCs is not substantial. The decrease of 2,3-diphosphoglycerate (DPG) in RBCs is proportional to the storage time. It results in the shift of the hemoglobin dissociation curve to the right and increased affinity of hemoglobin for oxygen, leading to decreased release of oxygen to tissues and a risk of tissue hypoxia. In addition to 2,3-DPG reduction, RBC storage leads 
Conclusion
The detected changes in the plasma levels of biochemical parameters suggest the risk for developing hyperkalemia and hyperlactatemia, depending on the character of RBC products. 
